Evidence map›Paper›PMID 30001410›Full record

ArticlePloS one2018

Surfactant replacement therapy in combination with different non-invasive ventilation techniques in spontaneously-breathing, surfactant-depleted adult rabbits.

Francesca Ricci, Costanza Casiraghi, Matteo Storti, Francesco D'Alò, Chiara Catozzi, Roberta Ciccimarra, Francesca Ravanetti, Antonio Cacchioli, Gino Villetti, Maurizio Civelli and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Excipient Enhanced Growth Aerosol Surfactant Replacement Therapy in anJournal of aerosol medicine and pulmonary drug delivery · 2020
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Francesca RicciChiesi Farmaceutici, R&D Department, Parma, Italy.
Costanza CasiraghiChiesi Farmaceutici, R&D Department, Parma, Italy.ORCID 0000-0001-6225-5250
Matteo StortiChiesi Farmaceutici, R&D Department, Parma, Italy.
Francesco D'AlòChiesi Farmaceutici, R&D Department, Parma, Italy.
Chiara CatozziChiesi Farmaceutici, R&D Department, Parma, Italy.
Roberta CiccimarraDepartment of Veterinary Science, University of Parma, Parma, Italy.
Francesca RavanettiDepartment of Veterinary Science, University of Parma, Parma, Italy.
Antonio CacchioliDepartment of Veterinary Science, University of Parma, Parma, Italy.
Gino VillettiChiesi Farmaceutici, R&D Department, Parma, Italy.
Maurizio CivelliChiesi Farmaceutici, R&D Department, Parma, Italy.
Xabi MurgiaDepartment of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Virgilio CarnielliDivision of Neonatology, Polytechnic University of Marche and Salesi Children's Hospital, Ancona, Italy.
Fabrizio SalomoneChiesi Farmaceutici, R&D Department, Parma, Italy.
Chiesi (Italy) · ITUniversity of Parma · ITHelmholtz Institute for Pharmaceutical Research Saarland · DEMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasal intermittent positive pressure ventilation (NIPPV) holds great potential as a primary ventilation support method for Respiratory Distress Syndrome (RDS). The use of NIPPV may also be of great value combined with minimally invasive surfactant delivery. Our aim was to implement an in vivo model of RDS, which can be managed with different non-invasive ventilation (NIV) strategies, including non-synchronized NIPPV, synchronized NIPPV (SNIPPV), and nasal continuous positive airway pressure (NCPAP). Forty-two surfactant-depleted adult rabbits were allocated in six different groups: three groups of animals were treated with only NIV for three hours (NIPPV, SNIPPV, and NCPAP groups), while three other groups were treated with surfactant (SF) followed by NIV (NIPPV+SF, SNIPPV+SF, and NCPAP+SF groups). Arterial gas exchange, ventilation indices, and dynamic compliance were assessed. Post-mortem the lungs were sampled for histological evaluation. Surfactant depletion was successfully achieved by repeated broncho-alveolar lavages (BALs). After BALs, all animals developed a moderate respiratory distress, which could not be reverted by merely applying NIV. Conversely, surfactant administration followed by NIV induced a rapid improvement of arterial oxygenation in all surfactant-treated groups. Breath synchronization was associated with a significantly better response in terms of gas exchange and dynamic compliance compared to non-synchronized NIPPV, showing also the lowest injury scores after histological assessment. The proposed in vivo model of surfactant deficiency was successfully managed with NCPAP, NIPPV, or SNIPPV; this model resembles a moderate respiratory distress and it is suitable for the preclinical testing of less invasive surfactant administration techniques.

Indexed as

Positive-Pressure RespirationAnimalsDisease Models, AnimalPulmonary SurfactantsRabbitsRespiratory Distress SyndromePulmonary Surfactants

Identifiers

PMID30001410
PMCPMC6042776
OpenAlexW2825606548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.